Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M207982200 on October 11, 2002

J. Biol. Chem., Vol. 277, Issue 50, 48816-48826, December 13, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/50/48816    most recent
M207982200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yao, X.-J.
Right arrow Articles by Cohen, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yao, X.-J.
Right arrow Articles by Cohen, E. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Genetic Selection of Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Vpr*

Xiao-Jian YaoDagger , Julie Lemay, Nicole Rougeau, Martin Clément§, Steve Kurtz, Pierre Belhumeur, and Éric A. Cohen||

From the Laboratoire de Rétrovirologie Humaine, Département de Microbiologie et Immunologie, Faculté de Médecine, Université de Montréal, Montréal, Québec H3C 3J7, Canada and  Northwest Neurologic Inc., Portland, Oregon 97210

Human immunodeficiency virus 1 (HIV-1) encodes a gene product, Vpr, that facilitates the nuclear uptake of the viral pre-integration complex in non-dividing cells and causes infected cells to arrest in the G2 phase of the cell cycle. Vpr was also shown to cause mitochondrial dysfunction in human cells and budding yeasts, an effect that was proposed to lead to growth arrest and cell killing in budding yeasts and apoptosis in human cells. In this study, we used a genetic selection in Saccharomyces cerevisiae to identify hexameric peptides that suppress the growth arrest phenotype mediated by Vpr. Fifteen selected glutathione S-transferase (GST)-fused peptides were found to overcome to different extents Vpr-mediated growth arrest. Amino acid analysis of the inhibitory peptide sequences revealed the conservation of a di-tryptophan (diW) motif. DiW-containing GST-peptides interacted with Vpr in GST pull-down assays, and their level of interaction correlated with their ability to overcome Vpr-mediated growth arrest. Importantly, Vpr-binding GST-peptides were also found to alleviate Vpr-mediated apoptosis and G2 arrest in HIV-1-producing CD4+ T cell lines. Furthermore, they co-localized with Vpr and interfered with its nuclear translocation. Overall, this study defines a class of diW-containing peptides that inhibit HIV-1 Vpr biological activities most likely by interacting with Vpr and interfering with critical protein interactions.


* This work was supported by grants from the Canadian Institute of Health Research and the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) network of excellence (to E. A. C.), the National Science and Engineering Research Council (to P. B.), and Fonds pour les Chercheurs et l'Aide à la Recherche (to E. A. C. and P. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a Médecine-Relève 2000 Messenger Foundation Award from the Faculté de Médecine, Université de Montréal.

§ Supported by a doctoral scholarship from the Fonds pour les Chercheurs et l'Aide à la Recherche.

|| Recipient of the Canada Research Chair in Human Retrovirology. To whom correspondence should be addressed. Tel.: 514-343-5967; Fax: 514-343-5995; E-mail: eric.cohen@umontreal.ca.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Chen, E. Le Rouzic, J. A. Kearney, L. M. Mansky, and S. Benichou
Vpr-mediated Incorporation of UNG2 into HIV-1 Particles Is Required to Modulate the Virus Mutation Rate and for Replication in Macrophages
J. Biol. Chem., July 2, 2004; 279(27): 28419 - 28425.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Zander, M. P. Sherman, U. Tessmer, K. Bruns, V. Wray, A. T. Prechtel, E. Schubert, P. Henklein, J. Luban, J. Neidleman, et al.
Cyclophilin A Interacts with HIV-1 Vpr and Is Required for Its Functional Expression
J. Biol. Chem., October 31, 2003; 278(44): 43202 - 43213.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement